All Baptist Health Medical Group (by Year) | Baptist Health Medical Group | Baptist Health South Florida

Menu

Skip to main content

All Baptist Health Medical Group (by Year)

Submissions from 2018 2018

Abstract 17123: Hierarchical Clustering in 2014 Medical Expenditure Panel Survey (MEPS) to Examine the Cost of Events Related to Acute Myocardial Infraction (AMI) and Hypertension (HTN), Anshul Saxena and Emir Veledar

Abstract 17153: Trends in Coronary Revascularization Among Cancer Patients in the United States, 2005-2014, Muni Rubens, Anshul Saxena, Peter McGranaghan, Sankalp Das, Deborah Suarez, Brittany Puebla, Alexandra Guida, and Emir Veledar

A Real World Experience of the FAST-ED Based Pre-Hospital Stroke Triage System to Detect Large Vessel Occlusions, Ned Shashoua, Amy Starosciak, Jayme Strauss, and Felipe De Los Rios La Rosa

Associations between self-reported periodontal disease, assessed using a very short questionnaire, cardiovascular disease events and all-cause mortality in a contemporary multi-ethnic population: The Multi-Ethnic Study of Atherosclerosis (MESA), Khurram Nasir

Dosimetric Impact of Large Displacement of the Metal Port of the Tissue Expander in Intensity Modulated Proton Therapy, Jen Yu, Jaafar Bennouna, and Minesh Mehta

Fully Automated 10-Minute 3D CAIPIRINHA SPACE TSE MRI of the Knee in Adults: A Multicenter, Multireader, Multifield-Strength Validation Study, Derek Papp

Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study, Arthur Agatston

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero

Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer, Minesh Mehta

Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study, Minesh Mehta

Robotic resection of Stage III lung cancer: an international retrospective study, Mark Dylewski

Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing, Rupesh Kotecha

Ten-Year Outcomes and Toxicity with Moderately Hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer, Rupesh Kotecha

The prognostic value of interleukin 6 in multiple chronic diseases and all-cause death: The Multi-Ethnic Study of Atherosclerosis (MESA), Khurram Nasir

Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus, Minesh Mehta

What is the evidence for the clinical value of SBRT in cancer of the cervix?, Minesh Mehta

Alcohol Consumption and Risk of Thyroid Cancer: A Population Based Case-Control Study in Connecticut, Robert Udelsman

Proton therapy patterns of care among pediatric and adult patients with CNS tumors, Rupesh Kotecha

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial, Minesh Mehta

Billing and Coding in Sports Medicine, Michael Swartzon

Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres, Michael Chuong

Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma, Rupesh Kotecha

EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors, Fernando Vargas Madueno, Edwin Gould, Raul Valor, and Miguel Villalona Calero

Open versus robotic-assisted transabdominal preperitoneal (R-TAPP) inguinal hernia repair: a multicenter matched analysis of clinical outcomes, Anthony Gonzalez

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC), Miguel Villalona Calero